It was shown in further preclinical studies that RNA interference was able to knock down YY1, and this promoted apoptosis, inhibited cell proliferation, and enhanced the effectiveness of chemotherapy in tumor cells for these trials [11,46,116]. Here, YY1 is linked to neoplasm.